Cargando…

PEARLS – A multicentre phase II/III trial of extended field radiotherapy for androgen sensitive prostate cancer patients with PSMA‐avid pelvic and/or para-aortic lymph nodes at presentation

PEARLS is a multi-stage randomised controlled trial for prostate cancer patients with pelvic and/or para-aortic PSMA-avid lymph node disease at presentation. The aim of the trial is to determine whether extending the radiotherapy field to cover the para-aortic lymph nodes (up to L1/L2 vertebral inte...

Descripción completa

Detalles Bibliográficos
Autores principales: Murray, Julia, Cruickshank, Clare, Bird, Thomas, Bell, Philip, Braun, John, Chuter, Dave, Ferreira, Miguel Reis, Griffin, Clare, Hassan, Shama, Hujairi, Nabil, Melcher, Alan, Miles, Elizabeth, Naismith, Olivia, Panades, Miguel, Philipps, Lara, Reid, Alison, Rekowski, Jan, Sankey, Pete, Staffurth, John, Syndikus, Isabel, Tree, Alison, Wilkins, Anna, Hall, Emma
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9550847/
https://www.ncbi.nlm.nih.gov/pubmed/36238579
http://dx.doi.org/10.1016/j.ctro.2022.09.003
_version_ 1784805974012329984
author Murray, Julia
Cruickshank, Clare
Bird, Thomas
Bell, Philip
Braun, John
Chuter, Dave
Ferreira, Miguel Reis
Griffin, Clare
Hassan, Shama
Hujairi, Nabil
Melcher, Alan
Miles, Elizabeth
Naismith, Olivia
Panades, Miguel
Philipps, Lara
Reid, Alison
Rekowski, Jan
Sankey, Pete
Staffurth, John
Syndikus, Isabel
Tree, Alison
Wilkins, Anna
Hall, Emma
author_facet Murray, Julia
Cruickshank, Clare
Bird, Thomas
Bell, Philip
Braun, John
Chuter, Dave
Ferreira, Miguel Reis
Griffin, Clare
Hassan, Shama
Hujairi, Nabil
Melcher, Alan
Miles, Elizabeth
Naismith, Olivia
Panades, Miguel
Philipps, Lara
Reid, Alison
Rekowski, Jan
Sankey, Pete
Staffurth, John
Syndikus, Isabel
Tree, Alison
Wilkins, Anna
Hall, Emma
author_sort Murray, Julia
collection PubMed
description PEARLS is a multi-stage randomised controlled trial for prostate cancer patients with pelvic and/or para-aortic PSMA-avid lymph node disease at presentation. The aim of the trial is to determine whether extending the radiotherapy field to cover the para-aortic lymph nodes (up to L1/L2 vertebral interspace) can improve outcomes for this patient group.
format Online
Article
Text
id pubmed-9550847
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-95508472022-10-12 PEARLS – A multicentre phase II/III trial of extended field radiotherapy for androgen sensitive prostate cancer patients with PSMA‐avid pelvic and/or para-aortic lymph nodes at presentation Murray, Julia Cruickshank, Clare Bird, Thomas Bell, Philip Braun, John Chuter, Dave Ferreira, Miguel Reis Griffin, Clare Hassan, Shama Hujairi, Nabil Melcher, Alan Miles, Elizabeth Naismith, Olivia Panades, Miguel Philipps, Lara Reid, Alison Rekowski, Jan Sankey, Pete Staffurth, John Syndikus, Isabel Tree, Alison Wilkins, Anna Hall, Emma Clin Transl Radiat Oncol Article PEARLS is a multi-stage randomised controlled trial for prostate cancer patients with pelvic and/or para-aortic PSMA-avid lymph node disease at presentation. The aim of the trial is to determine whether extending the radiotherapy field to cover the para-aortic lymph nodes (up to L1/L2 vertebral interspace) can improve outcomes for this patient group. Elsevier 2022-09-24 /pmc/articles/PMC9550847/ /pubmed/36238579 http://dx.doi.org/10.1016/j.ctro.2022.09.003 Text en © 2022 The Author(s) https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Article
Murray, Julia
Cruickshank, Clare
Bird, Thomas
Bell, Philip
Braun, John
Chuter, Dave
Ferreira, Miguel Reis
Griffin, Clare
Hassan, Shama
Hujairi, Nabil
Melcher, Alan
Miles, Elizabeth
Naismith, Olivia
Panades, Miguel
Philipps, Lara
Reid, Alison
Rekowski, Jan
Sankey, Pete
Staffurth, John
Syndikus, Isabel
Tree, Alison
Wilkins, Anna
Hall, Emma
PEARLS – A multicentre phase II/III trial of extended field radiotherapy for androgen sensitive prostate cancer patients with PSMA‐avid pelvic and/or para-aortic lymph nodes at presentation
title PEARLS – A multicentre phase II/III trial of extended field radiotherapy for androgen sensitive prostate cancer patients with PSMA‐avid pelvic and/or para-aortic lymph nodes at presentation
title_full PEARLS – A multicentre phase II/III trial of extended field radiotherapy for androgen sensitive prostate cancer patients with PSMA‐avid pelvic and/or para-aortic lymph nodes at presentation
title_fullStr PEARLS – A multicentre phase II/III trial of extended field radiotherapy for androgen sensitive prostate cancer patients with PSMA‐avid pelvic and/or para-aortic lymph nodes at presentation
title_full_unstemmed PEARLS – A multicentre phase II/III trial of extended field radiotherapy for androgen sensitive prostate cancer patients with PSMA‐avid pelvic and/or para-aortic lymph nodes at presentation
title_short PEARLS – A multicentre phase II/III trial of extended field radiotherapy for androgen sensitive prostate cancer patients with PSMA‐avid pelvic and/or para-aortic lymph nodes at presentation
title_sort pearls – a multicentre phase ii/iii trial of extended field radiotherapy for androgen sensitive prostate cancer patients with psma‐avid pelvic and/or para-aortic lymph nodes at presentation
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9550847/
https://www.ncbi.nlm.nih.gov/pubmed/36238579
http://dx.doi.org/10.1016/j.ctro.2022.09.003
work_keys_str_mv AT murrayjulia pearlsamulticentrephaseiiiiitrialofextendedfieldradiotherapyforandrogensensitiveprostatecancerpatientswithpsmaavidpelvicandorparaaorticlymphnodesatpresentation
AT cruickshankclare pearlsamulticentrephaseiiiiitrialofextendedfieldradiotherapyforandrogensensitiveprostatecancerpatientswithpsmaavidpelvicandorparaaorticlymphnodesatpresentation
AT birdthomas pearlsamulticentrephaseiiiiitrialofextendedfieldradiotherapyforandrogensensitiveprostatecancerpatientswithpsmaavidpelvicandorparaaorticlymphnodesatpresentation
AT bellphilip pearlsamulticentrephaseiiiiitrialofextendedfieldradiotherapyforandrogensensitiveprostatecancerpatientswithpsmaavidpelvicandorparaaorticlymphnodesatpresentation
AT braunjohn pearlsamulticentrephaseiiiiitrialofextendedfieldradiotherapyforandrogensensitiveprostatecancerpatientswithpsmaavidpelvicandorparaaorticlymphnodesatpresentation
AT chuterdave pearlsamulticentrephaseiiiiitrialofextendedfieldradiotherapyforandrogensensitiveprostatecancerpatientswithpsmaavidpelvicandorparaaorticlymphnodesatpresentation
AT ferreiramiguelreis pearlsamulticentrephaseiiiiitrialofextendedfieldradiotherapyforandrogensensitiveprostatecancerpatientswithpsmaavidpelvicandorparaaorticlymphnodesatpresentation
AT griffinclare pearlsamulticentrephaseiiiiitrialofextendedfieldradiotherapyforandrogensensitiveprostatecancerpatientswithpsmaavidpelvicandorparaaorticlymphnodesatpresentation
AT hassanshama pearlsamulticentrephaseiiiiitrialofextendedfieldradiotherapyforandrogensensitiveprostatecancerpatientswithpsmaavidpelvicandorparaaorticlymphnodesatpresentation
AT hujairinabil pearlsamulticentrephaseiiiiitrialofextendedfieldradiotherapyforandrogensensitiveprostatecancerpatientswithpsmaavidpelvicandorparaaorticlymphnodesatpresentation
AT melcheralan pearlsamulticentrephaseiiiiitrialofextendedfieldradiotherapyforandrogensensitiveprostatecancerpatientswithpsmaavidpelvicandorparaaorticlymphnodesatpresentation
AT mileselizabeth pearlsamulticentrephaseiiiiitrialofextendedfieldradiotherapyforandrogensensitiveprostatecancerpatientswithpsmaavidpelvicandorparaaorticlymphnodesatpresentation
AT naismitholivia pearlsamulticentrephaseiiiiitrialofextendedfieldradiotherapyforandrogensensitiveprostatecancerpatientswithpsmaavidpelvicandorparaaorticlymphnodesatpresentation
AT panadesmiguel pearlsamulticentrephaseiiiiitrialofextendedfieldradiotherapyforandrogensensitiveprostatecancerpatientswithpsmaavidpelvicandorparaaorticlymphnodesatpresentation
AT philippslara pearlsamulticentrephaseiiiiitrialofextendedfieldradiotherapyforandrogensensitiveprostatecancerpatientswithpsmaavidpelvicandorparaaorticlymphnodesatpresentation
AT reidalison pearlsamulticentrephaseiiiiitrialofextendedfieldradiotherapyforandrogensensitiveprostatecancerpatientswithpsmaavidpelvicandorparaaorticlymphnodesatpresentation
AT rekowskijan pearlsamulticentrephaseiiiiitrialofextendedfieldradiotherapyforandrogensensitiveprostatecancerpatientswithpsmaavidpelvicandorparaaorticlymphnodesatpresentation
AT sankeypete pearlsamulticentrephaseiiiiitrialofextendedfieldradiotherapyforandrogensensitiveprostatecancerpatientswithpsmaavidpelvicandorparaaorticlymphnodesatpresentation
AT staffurthjohn pearlsamulticentrephaseiiiiitrialofextendedfieldradiotherapyforandrogensensitiveprostatecancerpatientswithpsmaavidpelvicandorparaaorticlymphnodesatpresentation
AT syndikusisabel pearlsamulticentrephaseiiiiitrialofextendedfieldradiotherapyforandrogensensitiveprostatecancerpatientswithpsmaavidpelvicandorparaaorticlymphnodesatpresentation
AT treealison pearlsamulticentrephaseiiiiitrialofextendedfieldradiotherapyforandrogensensitiveprostatecancerpatientswithpsmaavidpelvicandorparaaorticlymphnodesatpresentation
AT wilkinsanna pearlsamulticentrephaseiiiiitrialofextendedfieldradiotherapyforandrogensensitiveprostatecancerpatientswithpsmaavidpelvicandorparaaorticlymphnodesatpresentation
AT hallemma pearlsamulticentrephaseiiiiitrialofextendedfieldradiotherapyforandrogensensitiveprostatecancerpatientswithpsmaavidpelvicandorparaaorticlymphnodesatpresentation
AT pearlsamulticentrephaseiiiiitrialofextendedfieldradiotherapyforandrogensensitiveprostatecancerpatientswithpsmaavidpelvicandorparaaorticlymphnodesatpresentation